𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endovascular treatment of thoracic aortic disease: Mid-term follow-up

✍ Scribed by Maurizio Tespili; Carlo Banfi; Orazio Valsecchi; Luigi Aiazzi; Cristina Ricucci; Giulio Guagliumi; Giuseppe Musumeci; Paolo Ferrazzi; Michael D. Dake


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
182 KB
Volume
70
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective:

The aim of this study was to evaluate the mid‐term follow‐up in a cohort of patients with acute or chronic descending aortic disease treated by stent‐graft repair.

Background:

Since 1999, endovascular stent‐graft placement has been reported as an alternative treatment to surgical approach for a variety of thoracic aortic diseases; however, results beyond initial short‐term follow‐up are not widely available for the broad range of applications.

Methods:

From March 2001, 43 consecutive patients with traumatic aortic transection (group A = 16) and complicated type B aortic dissection or aneurysm (group B = 27) underwent stent‐graft implantation. All patients underwent computed tomography (CT) scan as preoperative assessment and in 26 a transesophageal echo (TEE) exam was performed.

Results:

Technically successful stent‐graft deployment was achieved in all patients. No patient required surgical conversion and no cases of paraplegia occurred. The overall in‐hospital mortality was 9.3%. A residual endoleak (type II) was detected in one group B patient who was managed conservatively. The mean follow‐up was 29 ± 8 months (range 10–48 months). No patient died during late follow‐up after hospital discharge. At 12 months, one patient (2.5%) who had stent graft repair of an aortic dissection developed an asymptomatic type I endoleak. Three asymptomatic patients with chronic dissection had a persistent retrograde perfusion of the thoracic false lumen via a distal tear(s) in the dissection septum.

Conclusion:

Our results of stent‐graft treatment of complicated and uncomplicated diseases of the descending aorta confirms that this alternative to open repair is a safe, less invasive, and relatively low risk approach. Medium‐term follow‐up results suggest that it is effective and durable therapy with low associated mortality and morbidity rates. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Surgical treatment for Graves' disease:
✍ Shiro Noguchi; N. Murakami; A. Noguchi 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB 👁 2 views

## Abstract Postoperative thyroid status was classified into 6 categories on the basis of serum free thyroxine index (FTI), serum triiodothyronine (T-3) and serum TSH concentration. Review of 325 patients who underwent thyroidectomy for Graves' disease more than 4 years previously showed that 25 pa

Early treatment of Menkes disease with p
✍ Christodoulou, John; Danks, David M.; Sarkar, Bibudhendra; Baerlocher, Kurt E.; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

We report on the long-term clinical course of 4 boys with Menkes disease, treated from early infancy with parenteral copperhistidine, with follow-up over 10-20 years. Three of the 4 had male relatives with a severe clinical course compatible with classical Menkes disease. As a consequence of early t

Apomorphine monotherapy in the treatment
✍ Alice J. Manson; Kirsten Turner; Andrew J. Lees 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

Continuous subcutaneous infusion of apomorphine is now increasingly recognized as an effective treatment for refractory off periods and peak-dose dyskinesias in Parkinson's disease. We have reviewed our experience with apomorphine infusions, after a strategy decision in 1995 based on emerging precli